MUMBAI, India, December 9, 2013 /PRNewswire/ --
Bharat Book Bureau presents Alzheimer's Pipeline Drugs Review, Alzheimer's disease Drug Market & Forecast - Global Analysis. This report Alzheimer's disease drug market is on the curvature stage. Since 2003, there is not any single "magic bullet" launched in the market to prevent or cure it. However, all current marketed products are going to be generic in the next 3-4 years. There are high unmet medical needs. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies. If successful, they will be in a position to command premium prices and tap the existing opportunity. Lot of drugs has failed in Phase III stage thus putting a greater impact on Alzheimer's disease drug market. (http://www.bharatbook.com/healthcare-market-research-reports/alzheimers-pipeline-drugs-review-alzheimers-disease-drug-market-forecast-global-analysis.html)
(Logo: http://photos.prnewswire.com/prnh/20130128/590935 )
From the year 2009 Alzheimer's disease drug market is declining and it is expected to fall till 2016. But with the expected launch of some Alzheimer's drugs from the year 2017 onwards, Alzheimer's disease drug market is expected to revive in the coming years. However due to absence of exact potential drugs there will always remain a huge Unmet Alzheimer's Drug Market. For the year 2018 Alzheimer's disease Drug Market will be just 10% of Unmet Alzheimer's Disease Drug Market.
"Alzheimer's Pipeline Drugs Review, Alzheimer's Disease Drug Market & Forecast - Global Analysis" provides a comprehensive assessment of the fast-evolving, high-growth Global Alzheimer's Disease Market. This 110 page report with 29 Figures and 11 Tables studies the Global Alzheimer's Disease Drug Market.
Present & Pipeline Drugs Studied in this Report
This report contains 10 chapters.
Chapter 1: Executive Summary
Chapter 2: This Chapter is divided into 2 parts
Chapter 3: This chapter talks about drugs which has failed while in Clinical trials
Chapter 4: This chapter provides Market Share of Alzheimer's Disease Drug from 2003 to 2018. All the 9 Alzheimer's drug mentioned above have been covered in this chapter.
Chapter 5: This chapter talks about Alzheimer's Drugs performance. All important drugs mentioned above past, present & future market data available from 2003 to 2018.
Chapter 6: Pipeline drugs (Solanezumab, LuAE58054, Gantenerumab, Crenezumab, TRx0237 (LMTX), MK-8931, ABT-126, and AZD-1446) have been analyzed in this chapter. All drugs have been analyzed from 5 view points:
Chapter 7: This chapter speaks of Alzheimer's Drugs Company deals in four areas
Chapter 8: This chapter studies Funding in Alzheimer's disease Drugs Research. We have covered 5 institutes which provides fund for the research.
Chapter 9: This chapter studies Growth Factors Driving the Alzheimer's disease Drug Market.
Chapter 10: This chapter studies Challenges/Hindrances faced by Alzheimer's disease Drug Market.
Table of Contents
Executive Summary
Worldwide - Alzheimer's Disease Drug Market Analysis
Failed Alzheimer's Drugs
Worldwide - Alzheimer's Disease Drug Market Share & Forecast
Pipeline Drugs Analysis in Alzheimer's disease Market
LuAE58054 - Lundbeck
Gantenerumab - Roche
Crenezumab - Genentech
TRx0237 (LMTX) - TauRx Therapeutics Ltd.
MK-8931 - Merck
ABT-126 - AbbVie
AZD-1446 - Targacept/AstraZeneca
M&A, Licensing Agreement, Strategic Alliances & Collaboration Deals in Alzheimer's disease Drug Market
Funding in Alzheimer's disease Drugs Research
Key Drivers of Growth in Global Alzheimer's disease Drug Market
Key Challenges in the Global Alzheimer's disease Drug Market
Request for sample pages: http://www.bharatbook.com/RequestSample.asp?pid=199411
For more information on the report: http://www.bharatbook.com/healthcare-market-research-reports/alzheimers-pipeline-drugs-review-alzheimers-disease-drug-market-forecast-global-analysis.html
Related Reports:
Related Category:
About Bharat Book Bureau
Bharat Book Bureau is the leading market research information aggregator that provides market research reports, industry analysis, company profiles, business reports, country reports, newsletters and online databases. Our clients include Corporate, Consulting firms, and Academic Institutions and Government departments across the globe. Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. The market research reports we provide, help global companies examine the different markets before setting up a business or expanding into different countries across the world. They give a complete perspective on the current market scenario, trends, segments and future outlook.
Contact us:
Poonam
Bharat Book Bureau
USA/Canada - 1-866-279-8368 (Toll free)
India: +91-22-27810772, 27810773
Blog: http://blog.bharatbook.com
E: poonam@bharatbook.com
W: http://www.bharatbook.com
Share this article